Virulence genes, quinolone and fluoroquinolone resistance, and phylogenetic background of uropathogenic Escherichia coli strains isolated in Japan

Japanese Journal of Infectious Diseases

Volumn 63, Issue 2, 2010, Pages 113-115

  Kawamura Sato, Kumiko ^a,b   Yoshida, Risa ^b   Shibayama, Keigo ^c   Ohta, Michio ^b  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CYTOTOXIC NECROTIZING FACTOR 1; FIMBRIA PROTEIN; GLUTAMIC ACID; HEMOLYSIN; LEVOFLOXACIN; NALIDIXIC ACID; PROTEIN HLYA; PROTEIN PAPA; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG; VALINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; GENETIC ASSOCIATION; JAPAN; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; PHYLOGENY; PREVALENCE; UROPATHOGENIC ESCHERICHIA COLI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; QUINOLONES; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE FACTORS; YOUNG ADULT;

EID: 77950670049     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sobel, J.-D. and Donald, K. (2005): Urinary tract infection. p. 875-883. In G.L. Mandell, J.E. Bennett, and R. Dolin (ed.), Principles and Practice of Infectious Diseases. 6th ed. Elsevier Inc., Philadelphia, Pa.
2. Karaca, Y., Coplu, N., Gozalan, A., et al. (2005): Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infection over the last 10 years. Int. J. Antimicrob. Agents, 26, 75-77.
3. Goettsch, W., van Pelt, W., Nagelkerke, N., et al. (2000): Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands. J. Antimicrob. Chemother., 46, 223-228.
4. Martinez-Martinez, L., Fernandez, F. and Perea, E.-J. (1999): Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J. Antimicrob. Chemother., 43, 277-279.
5. Velasco, M., Horcajada, J.-P., Mensa, J., et al. (2001): Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin. Infect. Dis., 33, 1682-1686.
6. Vila, J., Simon, K., Ruiz, J., et al. (2002): Are quinolone-resistant uropathogenic Escherichia coli less virulent? J. Infect. Dis., 186, 1039-1042.
7. Russo, T.-A. and Johnson, J.-R. (2000): Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis., 181, 1753-1754.
8. Johnson, J., Gajewski, A., Lesse, A.-J., et al. (2003): Extraintestinal pathogenic Escherichia coli as a cause of invasive non-urinary infections. J. Clin. Microbiol., 41, 5798-5802.
9. Horcajada, J.-P., Soto, S., Gajewski, A., et al. (2005): Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J. Clin. Microbiol., 43, 2962-2964.
10. Moreno, E., Prats, G., Sabaté, M., et al. (2006): Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J. Antimicrob. Chemother., 57, 204-211.
11. Johnson, J.-R., Kuskowski, M.-A., Owens, K., et al. (2003): Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J. Infect. Dis., 188, 759-768.
12. Piatti, G., Mannini, A., Balistreri, M., et al. (2008): Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J. Antimicrob. Chemother., 46, 480-487.
13. Takahashi, A., Muratani, T., Yasuda, M., et al. (2009): Genetic profiles of fluoroquinolone-resistant Escherichia coli isolated from cystitis: phylogeny, virulence factors, PAIusp-subtypes, and mutation patterns. J. Clin. Microbiol., 47, 791-795.
14. Johnson, J.-R. and Stell, A.-L. (2000): Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis., 181, 261-272.
15. Clermont, O., Bonacorsi, S. and Bingen, E. (2000): Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol., 66, 4555-4558.
16. Kanamaru, S., Kurazono, H., Nakano, M., et al. (2006): Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic-specific protein: comparison with phylogenetic groups. Int. J. Urol., 13, 754-760.